Drug Research
Critical Medicine Shortages – A Growing Concern For The EMA
During its meeting in March 2023, the Management Board of the European Medicines Agency (EMA) gave an update on the continued efforts of the agency's Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) to further monitor...
Clinical Trials
UK To Give Faster Clinical Trial Nods Following Setbacks
The UK government intends to make clinical trials more accessible in order to re-establish the country's reputation as a favoured location for pioneering research.
In a new initiative to jump-start the country's faltering life sciences goals, the Medicines and Healthcare...
Drug Research
Tardigrade Proteins Can Do Wonders To Certain Pharma Drugs
The study of how the microscopic creatures called tardigrades can survive extreme scenarios has led to a significant breakthrough that could go on to make lifesaving treatments available to people where there is no possibility of refrigeration. The research...
News
Inizio strengths senior team with DE&I appointment
Inizio a global strategic partner for health and life sciences with a full suite of advisory, medical, marketing, communications, and patient and stakeholder engagement services, has strengthened its senior leadership team with the appointment of Stefanie Christmas as its...
News
Abzena bolsters senior leadership team with two key appointments
Abzena, the leading end-to-end integrated CDMO for Antibody Drug Conjugates (ADCs) and complex biologic molecules, has strengthened its senior leadership team with the appointment of Joe Principe as Chief Commercial Officer, and Matthew Pinkston as Vice President, Program Management.
Having...
IT & Data Management
Stem Cell Robots For Cell Therapy To Be Trialled By MHRA, UK
The Medicines and Healthcare Products Regulatory Agency's (MHRA) UK stem cell bank is trailing a new and innovative robot that would grow stem cells.
The MHRA's UK Stem Cell Bank is examining a stem cell propagation robot over a period...
Drug Research
Medicine Price Negotiations – Pathways Chalked By The CMS
The Centers for Medicare & Medicaid Services issued preliminary instructions on March 15 on how it intends to negotiate medication pricing under Medicare, a power provided to the agency by 2022’s Inflation Reduction Act.
According to CMS officials, the clinical...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.